Lincoln Park Capital
Overview
Lincoln Park Capital is an investment group and asset management firm based in Chicago focused on opportunistic investing in public and private companies, real estate, and fund to fund strategies . The firm invests in a wide range of companies and industries emphasizing life sciences, specialty financing, energy and technology .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Onchilles Pharma | Nov 2025 | Series A Extension | Co-investor |
| Altamira Therapeutics Ltd. | Aug 2024 | Private Placement | Co-investor |
| Rediff.com India Ltd | Jul 2015 | Private Placement | Lead |
| Trefis | Aug 2012 | Series A Extension | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Lincoln Park Capital based?
Lincoln Park Capital is headquartered in Chicago, Illinois, United States.
When was Lincoln Park Capital founded?
Lincoln Park Capital was founded in 2010.
How many portfolio companies does Lincoln Park Capital have?
Lincoln Park Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Lincoln Park Capital's portfolio?
Recent investments visible on Caplight include Onchilles Pharma, Altamira Therapeutics Ltd., Altamira Therapeutics Ltd., Rediff.com India Ltd, Trefis.
What was Lincoln Park Capital's most recent investment?
Lincoln Park Capital's most recent investment on Caplight was in Onchilles Pharma in 2025.
What sectors does Lincoln Park Capital focus on?
Lincoln Park Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Consumer & Commerce, Mobility, Transportation & Logistics, Enterprise Software, Enterprise Software, Enterprise Software.
What company stages does Lincoln Park Capital focus on?
Lincoln Park Capital typically invests at the Early stage.
What is Lincoln Park Capital's AUM?
Lincoln Park Capital's assets under management are estimated between $0.0 and $50.0M.